05/13/2025
6:43 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
8:12 AM | Bicara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2025
6:45 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
5:35 PM | Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:21 PM | Bicara Therapeutics (Subject)
Meisner Lara (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
8:14 AM | Bicara Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G | |
01/13/2025
7:02 AM | Bicara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:30 PM | Bicara Therapeutics (Subject)
Invus Global Management, LLC (Filed by)
| Form SC 13G | |
09/26/2024
3:16 PM | Bicara Therapeutics (Subject)
Red Tree GP, LLC (Filed by)
| Form SC 13G | |
09/23/2024
3:17 PM | Bicara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D | |
09/18/2024
5:02 PM | Bicara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BCAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
09/18/2024
4:02 PM | Bicara Therapeutics (Issuer)
BONDERMAN DAVID (Reporting)
COULTER JAMES G (Reporting)
TPG GP A, LLC (Reporting)
WINKELRIED JON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
4:10 PM | Bicara Therapeutics (Subject)
TPG GP A, LLC (Filed by)
| Form SC 13D | |
09/18/2024
10:54 AM | Bicara Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
10:54 AM | Bicara Therapeutics (Issuer)
FIL Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
10:57 AM | Bicara Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
09/17/2024
5:16 PM | Bicara Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
Deerfield Mgmt V, L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund V, L.P. (Reporting)
Flynn James E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
4:49 PM | Bicara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:35 PM | Bicara Therapeutics (Issuer)
Mazumdar-Shaw Kiran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:35 PM | Bicara Therapeutics (Issuer)
Robertson Scott M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:38 PM | Bicara Therapeutics (Issuer)
Haviland Kate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:39 PM | Bicara Therapeutics (Issuer)
Biocon Ltd (Reporting)
Biocon Pharma Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:41 PM | Bicara Therapeutics (Issuer)
Simson Jake (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:42 PM | Bicara Therapeutics (Issuer)
LONBERG NILS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:45 PM | Bicara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/12/2024
11:15 PM | Bicara Therapeutics (Filer)
| Form EFFECT | |
09/12/2024
8:19 PM | Bicara Therapeutics (Issuer)
Hyep Ivan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:20 PM | Bicara Therapeutics (Issuer)
Meisner Lara (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:24 PM | Bicara Therapeutics (Issuer)
Simson Jake (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:27 PM | Bicara Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
7:58 PM | Bicara Therapeutics (Issuer)
FIL Ltd (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:00 PM | Bicara Therapeutics (Issuer)
FMR LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:00 PM | Bicara Therapeutics (Issuer)
Haviland Kate (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:00 PM | Bicara Therapeutics (Issuer)
Robertson Scott M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:00 PM | Bicara Therapeutics (Issuer)
Biocon Ltd (Reporting)
Biocon Pharma Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:01 PM | Bicara Therapeutics (Issuer)
NG CAROLYN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:03 PM | Bicara Therapeutics (Issuer)
LONBERG NILS (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:07 PM | Bicara Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
Deerfield Mgmt V, L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund V, L.P. (Reporting)
Flynn James E (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:07 PM | Bicara Therapeutics (Issuer)
Cohlhepp Ryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:09 PM | Bicara Therapeutics (Issuer)
Mazumdar Claire (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:11 PM | Bicara Therapeutics (Issuer)
Bowden Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the May 1st funding window clos |
09/12/2024
8:11 PM | Bicara Therapeutics (Issuer)
Mazumdar-Shaw Kiran (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:15 PM | Bicara Therapeutics (Issuer)
Raben David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
8:16 PM | Bicara Therapeutics (Issuer)
POWELL MICHAEL (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
7:48 PM | Bicara Therapeutics (Issuer)
BONDERMAN DAVID (Reporting)
COULTER JAMES G (Reporting)
TPG GP A, LLC (Reporting)
WINKELRIED JON (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
6:37 PM | Bicara Therapeutics (Filer)
| Form S-1MEF | |
09/12/2024
12:07 PM | Bicara Therapeutics (Filer)
| Form CERT | |
09/11/2024
3:23 PM | Bicara Therapeutics (Filer)
| Form S-1/A | |
09/10/2024
3:06 PM | Bicara Therapeutics (Filer)
| Form 8-A12B | |
09/06/2024
5:31 AM | Bicara Therapeutics (Filer)
| Form S-1/A | |
09/03/2024
6:26 AM | Bicara Therapeutics (Filer)
| Form S-1/A | |
08/22/2024
3:38 PM | Bicara Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
